Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active compound in medications like Wegovy, works by slowing stomach emptying and reducing hunger signals in the brain. Most patients who start semaglutide therapy remain on it for at least 12 to 24 months, with many continuing longer based on their response and goals. Understanding treatment timeline helps set realistic expectations for your weight loss journey.
Typical Duration of Semaglutide Treatment
Clinical trials show that patients achieving meaningful weight loss on semaglutide typically continue treatment for a minimum of 12 months. Many individuals remain on therapy for 18 to 24 months or longer, especially when they continue losing weight and haven't reached their target weight. The decision to stay on semaglutide depends on your personal weight loss goals, how your body responds, and whether you wish to maintain weight loss long-term.
Your dose may need to go up as your body adjusts, but your price won't—PlexusDx keeps monthly costs flat across all dose levels. Treatment isn't a one-size-fits-all timeline; some patients see significant results in 6 months and choose to continue, while others take 12 to 18 months to reach their desired outcome. A licensed PlexusDx healthcare provider will review your progress at regular intervals to decide if continuing, adjusting, or transitioning off therapy is best for you.
Factors That Determine How Long You'll Take Semaglutide
Your starting weight, target weight, and rate of weight loss all influence how long you'll remain on semaglutide therapy. Patients who need to lose a larger total amount of weight typically stay on treatment longer than those with smaller weight loss goals. Additionally, your individual metabolic response—how quickly your body sheds pounds and how well your appetite control improves—affects the recommended treatment length.
Genetic factors also play a role in therapy duration and response. The PlexusDx Precision Peptide Genetic Test examines key variants in the GLP1R and GIPR pathways, helping identify whether your genetic profile suggests stronger or more modest semaglutide responsiveness. Understanding these peptide-pathway insights can help predict whether you're likely to need 6 months, 12 months, or 24+ months of therapy to reach your goals.
What Happens When You Stop Semaglutide
Weight regain is common after stopping semaglutide if lifestyle changes like diet and exercise haven't been firmly established. Research shows that patients who discontinue semaglutide without sustained behavior modification may regain 30–50% of their lost weight within several months. This doesn't mean the medication failed; it reflects the biological reality that hunger hormones return to baseline when treatment ends.
Many patients choose to continue semaglutide long-term as a maintenance therapy at the lowest effective dose, viewing it as chronic weight management—similar to how people stay on blood pressure or cholesterol medications indefinitely. Others cycle off therapy after reaching goals, then restart if weight regain becomes problematic. Your PlexusDx provider can discuss the benefits and risks of each approach during your regular check-ins.
Cost and Access to Semaglutide Through PlexusDx
PlexusDx compounded semaglutide injections start at just $149 per month, with no insurance required and no membership fees. Whether you're on your medication for 6 months or 24 months, your monthly cost remains predictable and affordable—coverage extends to all 50 states through licensed 503A compounding pharmacies. HSA and FSA funds are also accepted, making therapy accessible for most budgets.
After your first month of treatment, you can add the PlexusDx Precision Peptide Genetic Test for $99 to gain personalized insights about your peptide pathway genetics and predicted medication response. This one-time investment helps optimize your treatment plan and realistic timeline expectations. For patients considering long-term therapy, PlexusDx transparent pricing and no dose-based fee increases mean you can plan your weight loss investment with confidence.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I stop semaglutide whenever I want, or do I need to taper off?
You can generally stop semaglutide without a medical taper, though your PlexusDx provider may recommend a gradual dose reduction to minimize rebound hunger symptoms. Stopping abruptly is medically safe but may feel uncomfortable as appetite returns over 1–2 weeks. Discuss your timing and approach with your healthcare team before discontinuing.
How long does semaglutide take to show results?
Most patients notice appetite suppression within days, but measurable weight loss typically appears after 4 weeks of consistent therapy. Significant results—10+ pounds—usually emerge by 8 to 12 weeks. Full weight loss potential often takes 6 to 12 months to achieve, depending on your starting point and individual metabolism.
Is semaglutide safe to use for 2+ years?
Yes, semaglutide has been studied and used safely for chronic weight management over multiple years. Long-term trial data shows no new safety signals beyond the known side effects like nausea and constipation. Your PlexusDx provider will monitor your health with regular check-ins and lab work if needed to ensure continued safety.
Will I gain weight back after stopping semaglutide?
Weight regain is likely if diet and exercise habits haven't been permanently changed, but the degree varies. Some patients maintain most of their loss with sustained lifestyle efforts, while others regain weight more quickly. Many choose to stay on a maintenance dose long-term to prevent regain rather than stopping entirely.
Can the Precision Peptide Genetic Test predict how long I'll need semaglutide?
The PlexusDx Precision Peptide Genetic Test examines variants in GLP1R, GIPR, and FTO pathways that influence how strongly you respond to semaglutide. Favorable genetic variants may predict faster, more robust results, potentially shortening your treatment timeline, while other patterns may suggest slower progress and need for longer therapy.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Journey: What Time Should I Take Wegovy for Best Results?
What Does the Ozempic Shot Look Like? A Guide to Its Appearance and Use